Computational analysis of bevacizumab binding with protein receptors for its potential anticancer activity

References

• Agarwal, D., Zafar, I., Ahmad, S. U., Kumar, S., Ain, Q. U., Sundaray, J. N. D K., & Rather, M. A. (2022). Structural, genomic information and computational analysis of emerging coronavirus (SARS-CoV-2). Bulletin of the National Research Centre, 46(1), 170. https://doi.org/10.1186/s42269-022-00861-6
   PubMedGoogle Scholar
• Ahmad, H. M., Abrar, M., Izhar, O., Zafar, I., Rather, M. A., Alanazi, A. M., Malik, A., Rauf, A., Bhat, M. A., Wani, T. A., & Khan, A. A. (2022). Characterization of fenugreek and its natural compounds targeting AKT-1 protein in cancer: Pharmacophore, virtual screening, and MD simulation techniques. Journal of King Saud University - Science, 34(6), 102186. https://doi.org/10.1016/j.jksus.2022.102186
   Web of Science ®Google Scholar
• Ali, M. K., Javaid, S., Afzal, H., Zafar, I., Fayyaz, K., Ain, Q. U., Rather, M. A., Hossain, M. J., Rashid, S., Khan, K. A., & Sharma, R. (2023). Exploring the multifunctional roles of quantum dots for unlocking the future of biology and medicine. Environmental Research, 232, 116290. https://doi.org/10.1016/j.envres.2023.116290
   PubMed Web of Science ®Google Scholar
• Ali, S., Ali, U., Qamar, A., Zafar, I., Yaqoob, M., Ul Ain, Q., Rashid, S., Sharma, R., Nafidi, H. A., Bin Jardan, Y. A., & Bourhia, M. (2023). Predicting the effects of rare genetic variants on oncogenic signaling pathways: A computational analysis of HRAS protein function. Frontiers in Chemistry, 11, 1173624.
   PubMed Web of Science ®Google Scholar
• Ali, S., Noreen, A., Qamar, A., Zafar, I., Ain, Q., Nafidi, H.-A., Bin Jardan, Y. A., Bourhia, M., Rashid, S., & Sharma, R. (2023). Amomum subulatum: A treasure trove of anti-cancer compounds targeting TP53 protein using in vitro and in silico techniques. Frontiers in Chemistry, 11, 1174363.
   PubMed Web of Science ®Google Scholar
• Al-Sha’er, M. A., Mansi, I., Almazari, I., & Hakooz, N. (2015). Evaluation of novel Akt1 inhibitors as anticancer agents using virtual co-crystallized pharmacophore generation. Journal of Molecular Graphics and Modelling, 62, 213–225. https://doi.org/10.1016/j.jmgm.2015.10.004
   PubMed Web of Science ®Google Scholar
• Arshad, I., Ahsan, M., Zafar, I., Sajid, M., Sehgal, S. A., Yousaf, W., Noor, A., Rashid, S., Garai, S., Moovendhan, M., & Sharma, R. (2023). Bioinformatics approaches in upgrading microalgal oil for advanced biofuel production through hybrid ORF protein construction. Biomass Conversion and Biorefinery, 1-21. https://doi.org/10.1007/s13399-023-04766-w
   Google Scholar
• Ashiru, M. A., Ogunyemi, S. O., Temionu, O. R., Ajibare, A. C., Cicero-Mfon, N. C., Ihekuna, O. A., Jagun, M. O., Abdulmumin, L., Adisa, Q. K., Asibor, Y. E., Okorie, C. J., Lawal, M. O., Babalola, M. O., Abdulrasaq, I. T., Salau, L. B., Olatunji, I. O., Bankole, M. A., Daud, A. B., & Adeyemi, A. O. (2023). Identification of EGFR inhibitors as potential agents for cancer therapy: Pharmacophore-based modeling, molecular docking, and molecular dynamics investigations. Journal of Molecular Modelling, 29(5), 128.
   PubMed Web of Science ®Google Scholar
• Bekker, G.-J., Yokochi, M., Suzuki, H., Ikegawa, Y., Iwata, T., Kudou, T., Yura, K., Fujiwara, T., Kawabata, T., & Kurisu, G. (2022). Protein Data Bank Japan: Celebrating our 20th anniversary during a global pandemic as the Asian hub of three dimensional macromolecular structural data. Protein Science: A Publication of the Protein Society, 31(1), 173–186. https://doi.org/10.1002/pro.4211
   PubMed Web of Science ®Google Scholar
• Bergsland, E. K. (2004). Update on clinical trials targeting vascular endothelial growth factor in cancer. American Journal of Health-System Pharmacy, 61(21 Suppl 5), S12–S20. https://doi.org/10.1093/ajhp/61.suppl_5.S12
   PubMed Web of Science ®Google Scholar
• Butt, S. S., Badshah, Y., Shabbir, M., & Rafiq, M. J. (2020). Molecular docking using chimera and autodock vina software for nonbioinformaticians. JMIR Bioinformatics and Biotechnology, 1(1), e14232. https://doi.org/10.2196/14232
   Google Scholar
• Chen, L., Yang, X., Luo, D., & Yu, W. (2016). Efficient production of a bioactive bevacizumab monoclonal antibody using the 2A self-cleavage peptide in transgenic rice callus. Frontiers in Plant Science, 7, 1156.
   PubMed Web of Science ®Google Scholar
• Dakowicz, D., Zajkowska, M., & Mroczko, B. J. I. (2022). Relationship between VEGF family members, their receptors and cell death in the neoplastic transformation of colorectal cancer. International Journal of Molecular Sciences, 23(6), 3375. https://doi.org/10.3390/ijms23063375
   PubMed Web of Science ®Google Scholar
• Davis, I. D., Martin, A. J., Stockler, M. R., Begbie, S., Chi, K. N., Chowdhury, S. I. MON., Coskinas, X., Frydenberg, M., Hague, W. E., Horvath, L. G., Joshua, A. M., Lawrence, N. J., Marx, G., McCaffrey, J., McDermott, R., McJannett, MA. R. GARET., North, S. A., Parnis, F., Parulekar, W., … Sweeney, C. J. (2019). Enzalutamide with standard first-line therapy in metastatic prostate cancer. The New England Journal of Medicine, 381(2), 121–131. https://doi.org/10.1056/NEJMoa1903835
   PubMed Web of Science ®Google Scholar
• Demir Cetinkaya, B., & Biray Avci, C. (2022). Molecular perspective on targeted therapy in breast cancer: A review of current status. Medical Oncology, 39(10), 149. https://doi.org/10.1007/s12032-022-01749-1
   PubMed Web of Science ®Google Scholar
• Dhanasekaran, R., Deutzmann, A., Mahauad-Fernandez, W. D., Hansen, A. S., Gouw, A. M., & Felsher, D. W. (2022). The MYC oncogene—The grand orchestrator of cancer growth and immune evasion. Nature Reviews. Clinical Oncology, 19(1), 23–36. https://doi.org/10.1038/s41571-021-00549-2
   PubMed Web of Science ®Google Scholar
• Fatima, M., Zafar, I., Ain, Q. U., Anwar, M. M., Yousaf, W., Rather, M. A., Nainu, F., & Sharma, R. (2023). Multifunctional analysis and antimicrobial activity of Adhatoda vasica: A traditional medicinal plant. Drug Metabolism and Personalized Therapy, 38(4):359–366.
   PubMedGoogle Scholar
• Filippo, L. D. D., Dos Santos, K. C., Hanck-Silva, G., de Lima, F. T., Gremião, M. P. D., & Chorilli, M. (2021). A critical review of biological properties, delivery systems and analytical/bioanalytical methods for determination of bevacizumab. Critical Reviews in Analytical Chemistry, 51(5), 445–453. https://doi.org/10.1080/10408347.2020.1743641
   PubMed Web of Science ®Google Scholar
• Guardiola, S., Varese, M., Sánchez-Navarro, M., & Giralt, E. (2019). A third shot at EGFR: New opportunities in cancer therapy. Trends in Pharmacological Sciences, 40(12), 941–955. https://doi.org/10.1016/j.tips.2019.10.004
   PubMed Web of Science ®Google Scholar
• Hollingsworth, S. A., & Dror, R. O. (2018). Molecular dynamics simulation for all. Neuron, 99(6), 1129–1143. https://doi.org/10.1016/j.neuron.2018.08.011
   PubMed Web of Science ®Google Scholar
• Huey, R., Morris, G. M., & Forli, S. (2012). Using AutoDock 4 and AutoDock vina with AutoDockTools: A tutorial. The Scripps Research Institute Molecular Graphics Laboratory.
   Google Scholar
• Ishikura, N., Sugimoto, M., Yorozu, K., Kurasawa, M., Wakita, D., & Kondoh, O. (2022). Effect of bevacizumab on a human breast cancer model that exhibited palbociclib-resistance by RB knockout. Cancer Diagnosis & Prognosis, 2(5), 533–541. https://doi.org/10.21873/cdp.10138
   PubMedGoogle Scholar
• Kellenberger, E., Muller, P., Schalon, C., Bret, G., Foata, N., & Rognan, D. J. (2006). sc-PDB: An annotated database of druggable binding sites from the Protein Data Bank. Journal of Chemical Information and Modeling, 46(2), 717–727. https://doi.org/10.1021/ci050372x
   PubMed Web of Science ®Google Scholar
• Kim, M. M., Umemura, Y., & Leung, D. (2018). Bevacizumab and glioblastoma: Past, present, and future directions. Cancer Journal, 24(4), 180–186. https://doi.org/10.1097/PPO.0000000000000326
   PubMed Web of Science ®Google Scholar
• Kutzner, C., Kniep, C., Cherian, A., Nordstrom, L., Grubmüller, H., de Groot, B. L., & Gapsys, V. (2022). GROMACS in the cloud: A global supercomputer to speed up alchemical drug design. Journal of Chemical Information and Modeling, 62(7), 1691–1711. https://doi.org/10.1021/acs.jcim.2c00044
   PubMed Web of Science ®Google Scholar
• Lang, J. E., Tseng, W. W., & Kang, I. (2019). A novel monoclonal antibody-targeting angiogenesis by inhibiting secreted frizzled-related protein 2. Annals of Surgical Oncology, 26(13), 4188–4190. https://doi.org/10.1245/s10434-019-07801-1
   PubMed Web of Science ®Google Scholar
• Lawal, H. A., Uzairu, A., & Uba, S. (2021). QSAR, molecular docking studies, ligand-based design and pharmacokinetic analysis on Maternal Embryonic Leucine Zipper Kinase (MELK) inhibitors as potential anti-triple-negative breast cancer (MDA-MB-231 cell line) drug compounds. Bulletin of the National Research Centre, 45, 1–20.
   Google Scholar
• Li, Z., Guo, F., Han, Y., Wang, J., & Xu, B. (2022). Efficacy and safety of bevacizumab in pretreated metastatic breast cancer: A systematic review and meta-analysis. Oncology Research and Treatment, 45(10), 608–617. https://doi.org/10.1159/000525882
   PubMed Web of Science ®Google Scholar
• Marriam, S., Afghan, M. S., Nadeem, M., Sajid, M., Ahsan, M., & Basit, A. (2023). Designing a potential multi-epitopes based vaccine against SARS-CoV-2 targeting C30 endopeptidase regions using immunoinformatics approaches. Microbiology, I, 13, 568.
   Google Scholar
• Massó-Vallés, D., & Soucek, L. (2020). Blocking Myc to treat cancer: Reflecting on two decades of omomyc. Cells, 9(4), 883. https://doi.org/10.3390/cells9040883
   PubMed Web of Science ®Google Scholar
• Neshich, G., Borro, L. C., Higa, R. H., Kuser, P. R., Yamagishi, M. E. B., Franco, E. H., Krauchenco, J. N., Fileto, R., Ribeiro, A. A., Bezerra, G. B. P., Velludo, T. M., Jimenez, T. S., Furukawa, N., Teshima, H., Kitajima, K., Bava, A., Sarai, A., Togawa, R. C., & Mancini, A. L. (2005). The diamond STING server. Nucleic Acids Research, 33(Web Server issue), W29–W35. https://doi.org/10.1093/nar/gki397
   PubMedGoogle Scholar
• Niu, G., & Chen, X. (2010). Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy. Current Drug Targets, 11(8), 1000–1017. https://doi.org/10.2174/138945010791591395
   PubMed Web of Science ®Google Scholar
• Nwaefulu, O. N., Sagineedu, S. R., Islam, M. K., & Stanslas, J. (2022). Pancreatic cancer treatment with targeted therapies: Are we there yet? European Review for Medical and Pharmacological Sciences, 26(2), 367–381.
   PubMed Web of Science ®Google Scholar
• Papadimitriou, M. C., Pazaiti, A., Iliakopoulos, K., Markouli, M., Michalaki, V., & Papadimitriou, C. A. (2022). Resistance to CDK4/6 inhibition: Mechanisms and strategies to overcome a therapeutic problem in the treatment of hormone receptor-positive metastatic breast cancer. Biochimica et Biophysica Acta. Molecular Cell Research, 1869(12), 119346. https://doi.org/10.1016/j.bbamcr.2022.119346
   PubMed Web of Science ®Google Scholar
• Peng, F., Wang, L., Xiong, L., Tang, H., Du, J., & Peng, C. (2022). Maackiain modulates miR-374a/GADD45A axis to inhibit triple-negative breast cancer initiation and progression. Frontiers in Pharmacology, 13, 806869.
   PubMed Web of Science ®Google Scholar
• Rafique, Q., Rehman, A., Afghan, M. S., Ahmad, H. M., Zafar, I., Fayyaz, K., Ain, Q., Rayan, R. A., Al-Aidarous, K. M., Rashid, S., Mushtaq, G., & Sharma, R. (2023). Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations. Computers in Biology and Medicine, 163, 107191. https://doi.org/10.1016/j.compbiomed.2023.107191
   PubMed Web of Science ®Google Scholar
• Ramadan, M. M., Ali, M. A., Albohy, A., Zada, S. K., Tolba, M. F., & Abu-ELElla, D. (2021). Molecular modeling studies on biochanin-A as a potential dual inhibitor for VEGFR-2 and cyclin D1-CDK-4 complex. Archives of Pharmaceutical Sciences Ain Shams University, 5(1), 16–32. https://doi.org/10.21608/aps.2021.59204.1050
   Google Scholar
• Rather, M. A., Dutta, S., Guttula, P. K., Dhandare, B. C., Yusufzai, S., & Zafar, M. I. (2020). Structural analysis, molecular docking and molecular dynamics simulations of G-protein-coupled receptor (kisspeptin) in fish. Journal of Biomolecular Structure & Dynamics, 38(8), 2422–2439. https://doi.org/10.1080/07391102.2019.1633407
   PubMed Web of Science ®Google Scholar
• Renagupita, M. S., Rahadianto, R., Garianto, E., & Setianingsih, H. (2023). Potential effect of phlorotannins in brown algae for antidiabetic therapy: Molecular docking approach. Makara Journal of Science, 27(1), 2.
   Web of Science ®Google Scholar
• Saleh, A. H., Abdelwaly, A., Darwish, K. M., Eissa, A. A., Chittiboyina, A., & Helal, M. A. (2021). Deciphering the molecular basis of the kappa opioid receptor selectivity: A Molecular Dynamics study. Journal of Molecular Graphics & Modelling, 106, 107940. https://doi.org/10.1016/j.jmgm.2021.107940
   PubMed Web of Science ®Google Scholar
• Sharma, S., Sharma, A., & Gupta, U. (2021). Molecular docking studies on the anti-fungal activity of Allium sativum (Garlic) against Mucormycosis (black fungus) by BIOVIA discovery studio visualizer 21.1.0.0. Annals of Antivirals Antiretrovirals, 5(1), 028–032.
   Google Scholar
• Sompel, K., Elango, A., Smith, A., & Tennis, M. (2021). Cancer chemoprevention through Frizzled receptors and EMT. Discover Oncology, 12, 1–15.
   Google Scholar
• Szklarczyk, D., Kirsch, R., Koutrouli, M., Nastou, K., Mehryary, F., Hachilif, R., Gable, A. L., Fang, T., Doncheva, N. T., Pyysalo, S., Bork, P., Jensen, L. J., & von Mering, C. (2023). The STRING database in 2023: Protein–protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Research, 51(D1), D638–D646. https://doi.org/10.1093/nar/gkac1000
   PubMed Web of Science ®Google Scholar
• Tabti, K., Ahmad, I., Zafar, I., Sbai, A., Maghat, H., Bouachrine, M., & Lakhlifi, T. (2023). Profiling the structural determinants of pyrrolidine derivative as gelatinases (MMP-2 and MMP-9) inhibitors using in silico approaches. Computational Biology and Chemistry, 104, 107855. https://doi.org/10.1016/j.compbiolchem.2023.107855
   PubMed Web of Science ®Google Scholar
• Tate, S., Nishikimi, K., Matsuoka, A., Otsuka, S., Shiko, Y., Ozawa, Y., Kawasaki, Y., & Shozu, M. (2021). Bevacizumab in first-line chemotherapy improves progression-free survival for advanced ovarian clear cell carcinoma. Cancers, 13(13), 3177. https://doi.org/10.3390/cancers13133177
   PubMed Web of Science ®Google Scholar
• Tsai, M., Valent, P., & Galli, S. (2022). KIT as a master regulator of the mast cell lineage. The Journal of Allergy and Clinical Immunology, 149(6), 1845–1854. https://doi.org/10.1016/j.jaci.2022.04.012
   PubMed Web of Science ®Google Scholar
• Ueno, K., Hirata, H., Hinoda, Y., & Dahiya, R. (2013). Frizzled homolog proteins, microRNAs and Wnt signaling in cancer. International Journal of Cancer, 132(8), 1731–1740. https://doi.org/10.1002/ijc.27746
   PubMed Web of Science ®Google Scholar
• Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., & Berendsen, H. (2005). GROMACS: Fast, flexible, and free. Journal of Computational Chemistry, 26(16), 1701–1718. https://doi.org/10.1002/jcc.20291
   PubMed Web of Science ®Google Scholar
• Wabel, A.-B., & Khajah, M. (2019). The principles behind targeted therapy for cancer treatment. In Tumor progression and metastasis. IntechOpen.
   Google Scholar
• Wang, H., Boussouar, A., Mazelin, L., Tauszig-Delamasure, S., Sun, Y., GolDSchneider, D., Paradisi, A., & Mehlen, P. (2018). The proto-oncogene c-Kit inhibits tumor growth by behaving as a dependence receptor. Molecular Cell, 72(3), 413–425.e5–e415. https://doi.org/10.1016/j.molcel.2018.08.040
   PubMed Web of Science ®Google Scholar
• Wesslowski, J., Kozielewicz, P., Wang, X., Cui, H., Schihada, H., Kranz, D., Karuna M, P., Levkin, P., Gross, J. C., Boutros, M., Schulte, G., & Davidson, G. (2020). eGFP-tagged Wnt-3a enables functional analysis of Wnt trafficking and signaling and kinetic assessment of Wnt binding to full-length Frizzled. The Journal of Biological Chemistry, 295(26), 8759–8774. https://doi.org/10.1074/jbc.RA120.012892
   PubMed Web of Science ®Google Scholar
• Wu, J., & Hicks, C. (2021). Breast cancer type classification using machine learning. Journal of Personalized Medicine, 11(2), 61. https://doi.org/10.3390/jpm11020061
   PubMed Web of Science ®Google Scholar
• Xu, J., Chen, Y., & Olopade, O. I. (2010). MYC and breast cancer. Genes & Cancer, 1(6), 629–640. https://doi.org/10.1177/1947601910378691
   PubMedGoogle Scholar
• Yasmin, A., Bukhari, S. A., Zahoor, M. K., Mustafa, G., & Rasul, A. (2020). Screening of novel phytochemicals as secreted frizzled-related protein 4 inhibitors: An early stage biomarker of type 2 diabetes. Pakistan Journal of Pharmaceutical Sciences, 33(3), 1245–1250.
   Web of Science ®Google Scholar
• Zafar, I., Iftikhar, R., Ahmad, S. U., & Rather, M. A. (2021). Genome wide identification, phylogeny, and synteny analysis of sox gene family in common carp (Cyprinus carpio). Biotechnology Reports, 30, e00607. https://doi.org/10.1016/j.btre.2021.e00607
   Google Scholar
• Zafar, I., Tariq Pervez, M., Rather, M. A., Ellahi Babar, M., Ali Raza, M., Iftikhar, R., & Fatima, M. (2020). Genome-wide identification and expression analysis of PPOs and POX gene families in the selected plant species. Biosciences Biotechnology Research Asia, 17(2), 301–318. https://doi.org/10.13005/bbra/2834
   Google Scholar
• Zafar, I., Rubab, A., Aslam, M., Ahmad, S. U., Liyaqat, I., Malik, A., Alam, M., Wani, T. A., & Khan, A. A. (2022). Genome-wide identification and analysis of GRF (growth-regulating factor) gene family in Camila sativa through in silico approaches. Journal of King Saud University-Science, 34(4), 102038. https://doi.org/10.1016/j.jksus.2022.102038
   Web of Science ®Google Scholar
• Zaman, N., Yousaf, R., Akhtar, Z., & Azam, S. S. (2023). Modulating structural dynamics of dual drugs for CDK4 complex addressing prostate cancer. Journal of Molecular Liquids, 376, 121454. https://doi.org/10.1016/j.molliq.2023.121454
   Web of Science ®Google Scholar